We investigated the effect of all-trans-retinoic acid (atRA) on proliferation in several human skin cell lines and found that antiproliferative potency of atRA correlated with the endogenous activity of canonical Wnt signaling. In HaCaT keratinocytes, we found that atRA significantly suppressed the expression of Id2, a member of the inhibitor of differentiation family of transcription factors that regulate cell growth and differentiation. However, no apparent change in the expression of other Wnt targets, like c-Myc or cyclin D1, was observed. Retinoid-induced Id2 gene suppression was associated with decreased levels of histone H3 and H4 acetylation and histone H3 Lys-4 methylation, and with recruitment of the LSD1 demethylase at the Wnt-response element (WRE) (TCF/LEF-binding site), in the Id2 gene promoter. None of such changes was detected at the WRE of c-Myc and cyclin D1 gene promoters. Inhibition of Id2 by short interfering RNA (siRNA) had a similar effect on the proliferation of HaCaT cells as exposure to atRA, whereas anti-b-catenin siRNA significantly inhibited its antiproliferative effect. These data suggest that downregulation of Id2 gene expression through transcriptional convergence between Wnt and retinoid signaling pathways underlies the antiproliferative effect of retinoids in keratinocytes, and provide evidence of gene-targeted crosstalk between signaling pathways.
Introduction
Retinoids, structural and functional analogues of vitamin A, play fundamental role in the regulation of growth, differentiation, homeostasis and apoptosis in many cells and tissues. The physiological action of retinoids is primarily mediated by the activities of two classes of nuclear receptors, retinoic acid receptors (RARa, RARb and RARg) and retinoid X receptors (RXRa, RXRb and RXRg). Upon ligand binding, these receptors form RXR-RAR heterodimers or RXR-RXR homodimers, which then bind to DNA response elements, RAREs or RXREs, leading to recruitment of activator or repressor complexes to modulate the expression of target genes. Retinoid receptors interact with intracellular mediators of other signaling pathways and modulate their regulatory action on their corresponding target genes, thereby increasing complexity of the pleiotropic effects of retinoids owing to crosstalk with different signaling pathways (Mark et al., 2006) . Vitamin A deficiency has been implicated in the etiology of various epithelial tumors. The chemopreventive and chemotherapeutic effects of some natural and synthetic retinoids, such as all-trans-retinoic acid (atRA), for various cancers, including head and neck, cervical, neuroblastoma, promyelocytic leukemia and cutaneous squamous cell carcinoma, have been well documented in clinical trials and experiments on animal models (Niles, 2004; Okuno et al., 2004 and references therein) . However, the molecular mechanisms of the antiproliferative action of retinoids in skin cells remain generally unclear.
Canonical Wnt signaling is activated by Wnt peptide ligands through interaction with frizzled (Fzd) plasma membrane receptors. This leads to stabilization and nuclear translocation of the intracellular transducer b-catenin. In the nucleus, b-catenin associates with members of the T-cell factor/lymphoid enhancer factor (TCF/LEF) family of transcriptional factors. TCF/ LEF-b-catenin complexes bind to TCF/LEF-binding sites, or Wnt-response elements (WRE), in the promoters of target genes, leading to their transcriptional activation. The crucial role of Wnt signaling in skin physiology and disease has been well established (Alonso and Fuchs, 2003; Weeraratna, 2005) . Canonical Wnt signaling converges with various hormone-signaling pathways through interaction with corresponding nuclear receptors. This crosstalk has been shown to play an important role in the regulation of many vital biological processes, including cell proliferation and carcinogenesis (Moon et al., 2004; Mulholland et al., 2005 and references therein).
Initially, RA was shown to suppress the expression of the Wnt/b-catenin-dependent reporter through direct interaction between RAR and b-catenin (Easwaran et al., 1999) . However, in different systems RA was found to increase levels and stability of the nuclear bcatenin, thereby enhancing the Wnt/b-catenin signaling (Liu et al., 2002; Otero et al., 2004) . Conversely, Wnt/ b-catenin enhances RAR transactivation (Easwaran et al., 1999) and synergizes with RAR in activation of RA-inducible genes (Szeto et al., 2001; Tice et al., 2002) .
We have studied the effect of atRA on proliferation in several human skin cell lines and found that the antiproliferative potency of atRA correlated with the endogenous activity of canonical Wnt signaling, but not retinoid signaling. Interaction between Wnt and retinoid signaling in regulation of proliferation has been further investigated in detail in HaCaT cells (Boukamp et al., 1988) , a widely accepted human keratinocyte model system. Here, we show that transcriptional downregulation of Id2 gene expression through crosstalk between Wnt and retinoid signaling pathways underlies the antiproliferative effect of retinoids in keratinocytes. Our data indicate that Id2 may represent a beneficial therapeutic target in treatment of epithelial tumors.
Results
We studied the effects of retinoids on cell proliferation in several human keratinocyte (HaCaT and SCC25) and melanocyte (A2058, A375 and G361) lines. After 48 h of exposure to 50 nM atRA, the rate of proliferation significantly decreased in HaCaT keratinocytes and squamous cell carcinoma SCC25 cells, slightly decreased in A375 and A2058 melanoma cells, but somewhat increased in G361 melanoma cells (Figure 1a) .
To investigate the factors responsible for selective effects of atRA on proliferation, activities of endogenous signaling pathways in these cell lines were analysed by expression of pathway-specific reporter genes. No apparent association was observed between the effects of atRA on cell proliferation and retinoid signaling, judged by the induction of RARE-dependent reporter expression (Figure 1b ). A375 cells showed the lowest activation of the reporter, but exhibited a small yet statistically significant reduction of BrdU incorporation in response to atRA. In comparison, G361 and SCC25 cells with high and seemingly comparable levels of endogenous retinoid signaling contrasted sharply in their response to atRA.
b-catenin-mediated Wnt signaling has been shown to activate the expression of many key regulators of proliferation, such as cyclin D1 and c-Myc. Therefore, we analysed endogenous Wnt signaling in these cells by using TOPFLASH (with a functional WRE) and FOPFLASH (as a normalizing control with mutated WRE that does not bind TCF/LEF factors) reporters. There appeared to be a correlation between the activity of endogenous Wnt signaling and the retinoid-induced decrease in the rate of proliferation (Figure 1c) . Growth of G361 cells with almost silent Wnt and high levels of endogenous retinoid signaling was rather stimulated by atRA. In contrast, proliferation of A375 cells with low levels of endogenous retinoid signaling decreased when treated with atRA.
We analysed the expression of genes encoding Wnt ligands and mediators of the retinoid and Wnt signaling pathways in two cell lines that contrasted most in their As b-catenin has a dual role as a structural protein and intracellular Wnt signal transducer, we compared levels of nuclear b-catenin in these cell lines by immunocytochemical staining. Although levels of b-catenin mRNA appeared to be higher in G361 cells, it was only reflected in stronger plasma membrane staining, whereas the cyto-or nucleoplasmic fluorescent staining of b-catenin protein in these cells was not visible (Figure 2b ). Lack or below-detectable levels of Wnt ligand expression is consistent with the apparent silence of the Wnt reporter and absence of nuclear staining of b-catenin in G361 cells.
To investigate further correlation between Wnt activity and action of retinoids, we analysed effects of activation and suppression of Wnt signaling in HaCaT cells on their proliferation in response to atRA. In these cells, additional activation of Wnt by treatment with Wnt3a resulted in a stimulation of cell growth in the presence of vehicle. However, there was a more prominent decrease in the rate of proliferation in response to atRA. In contrast, inhibition of Wnt with anti-b-catenin short interfering RNA (siRNA) markedly reduced both the basal rate of proliferation and antiproliferative effect of atRA in comparison to control cells transfected with nonspecific anti-GFP siRNA ( Figure 3a) . As total cellular levels of b-catenin do not reflect levels of the nuclear b-catenin that mediates Wnt, as it can be clearly seen above when comparing levels of b-catenin mRNA and Wnt activity in HaCaT and G361 cells (Figures 1c and 2 ), for control of Wnt activation by the Wnt3a ligand and suppression by anti-b-catenin siRNA, we used the activity of Wnt/b-catenin-dependent reporter as a functionally more relevant marker (Figure 3b) .
Overall, the above data show that the antiproliferative action of atRA involves crosstalk between Wnt and retinoid signaling pathways.
Next, we investigated potential target genes of this crosstalk in the HaCaT keratinocytes. Expression of several well-characterized Wnt targets (see www. stanford.edu/Brnusse/pathways/targets.html) and key regulators of cell-cycle progression were analysed by RT-PCR. Treatment with atRA produced no discernable differences in the levels of mRNA for cyclin D1, c-Myc, or EGFR and there was a slight decrease for CD44. However, exposure to atRA caused a significant reduction in Id2 gene expression (Figure 4a and b) .
Next, we investigated whether this suppression of the Id2 expression was direct and mediated by transcriptional interaction between RARs and b-catenin. Chromatin immunoprecipitation (ChIP) assay experiments showed that atRA induced recruitment of the RARs to the WRE of the Id2 (Figure 5a ), c-Myc (Figure 5b ) and cyclin D1 (not shown) gene promoters. However, only in the Id2 gene atRA triggered a marked reduction in the levels of histone H4 and H3 (not shown) acetylation and histone H3 K-4 methylation, a clear mark of transcriptional repression. This was associated with retinoiddependent recruitment of the LSD1 demethylase to the WRE in the promoter of the Id2 gene (Figure 5a ). At the same time, expression of the LSD1 itself was not affected by atRA. Despite a slight increase in the b-catenin binding, combined treatment with Wnt3a and atRA had no readily detectable effect on LSD1 recruitment to the WRE, probably owing to sensitivity We were not able to identify in the Id2 gene promoter a DNA sequence resembling known RARE or RXRE, and no functional RARE was identified in the cloned Id2 promoter in earlier studies (Neuman et al., 1995) . Nonetheless, we investigated whether RAR recruitment to the WRE at the Id2 promoter was entirely dependent on the binding of b-catenin. Transfection with b-catenin targeting siRNA significantly reduced the amounts of b-catenin bound to the Id2 gene WRE and it was associated with seemingly reciprocal reduction in the atRA-induced binding of RARs (Figure 5c ). This suggests that RAR binding to the WRE in the Id2 gene promoter is indirect and mediated by b-catenin.
It has been reported that retinoic acid does not affect levels of cyclin D1 mRNA, but promotes the ubiquitination and consequent degradation of cyclin D1 protein, and that proteasomal inhibitors block retinoid-induced decline in cyclin D1 (Ma et al., 2005) . In a different experimental system, glucocorticoid-induced decline in proliferation of neural stem cells was abrogated in the presence of 0.5 mM of a potent proteasomal inhibitor MG132, reflecting an involvement of the ubiquitin proteasomal pathway (Sundberg et al., 2006) . Furthermore, Id2 has been identified as a potential substrate for some E3 ubiquitin ligase complexes and, thus, can be targeted for proteasomal degradation (Lasorella et al., 2006) . Therefore, we investigated whether MG132 would be able to counteract the antiproliferative action of atRA in HaCaT cells.
Although without detectable effect on the total cellular b-catenin (data not shown), treatment with MG132 mildly stimulated proliferation of HaCaT cells (Figure 6a ), presumably owing to stabilization of signaling b-catenin (Aberle et al., 1997) . Nevertheless, inhibition of proteasomal proteolytic activity did not abrogate reduction in the rate of cell proliferation in response to atRA (Figure 6a ). This indicates that ubiquitin-targeted proteasomal degradation of cyclin D1, Id2 or any other proliferation-promoting factor is unlikely to play a major role in mechanisms of the antiproliferative action of retinoids in human keratinocytes. It should be noted, however, that besides the use of different cell lines, retinoic acid concentrations used in experiments reported by Ma et al. (2005) were about two orders of magnitude higher than those used in our study. It is conceivable that higher doses are required to activate the proteasomal regulatory pathway.
The significance of Id2 gene suppression in the mechanism of the retinoid-induced decrease in rate of proliferation in HaCaT cells was further tested by inhibition of Id2 expression with siRNA. We found that transfection with siRNA targeting Id2 mRNA resulted in a significant reduction in the rate of cell proliferation. Exposure to atRA did not markedly decrease the proliferation rate of these cells in comparison to control cells transfected with anti-GFP siRNA (Figure 6b) . Thus, transcriptional suppression of Id2 is a pivotal mechanism in the control of keratinocyte proliferation by retinoids.
Discussion
The Id (inhibitor of differentiation or DNA binding) helix-loop-helix transcription factors represent an important family of regulators of cellular growth and differentiation. Ectopic expression of Id proteins abrogates differentiation and can lead to cellular immortalization. In clinical studies, expression of members of the Id family significantly correlated both with cancer progression and overall prognosis, implying an important role of these regulatory proteins in carcinogenesis (Sikder et al, 2003) . Among other members, Id2 was found to play a crucial role in the regulation of differentiation, cell cycle and proliferation in epithelial cells. It acts as a dominant negative antagonist of Rb and abrogates the tumor suppressor function of Rb, thereby promoting entry into S phase and cell proliferation (Lasorella et al., 2001 (Lasorella et al., , 2005 .
In different cell systems, retinoids have been reported to downregulate (Neuman et al, 1995; Wagsater et al., 2003) and upregulate (Buzzard et al., 2003; Nigten et al, 2005) the Id2 gene expression. Overexpression of another helix-loop-helix transcription factor NSCL was shown to abrogate RA-induced downregulation of Id2 in F9 cells (Neuman et al., 1995) . The Id2 gene promoter harbors no DNA sequence, resembling known RAREs or RXREs (Neuman et al., 1995) , and RAR binding to the Id2 WRE is b-catenin-dependent (Figure 5c ) Thus, effects of atRA on the Id2 gene expression appear to be cell context-dependent and unlikely to be mediated by direct binding of the RARs to the gene promoter DNA.
We have shown that Id2 suppression through transcriptional interaction between Wnt and retinoid signaling transducers plays a key role in the control of keratinocyte proliferation by retinoids. Our data are in agreement with recent reports that Id2 abrogates girradiation-induced cell-cycle arrest in human keratinocytes (Baghdoyan et al., 2005) , and that upregulation of Id2 by UVB stimulates proliferation and predisposes keratinocytes to carcinogenesis by preventing their normal differentiation program (Simbulan-Rosenthal et al., 2005) . Significantly, among potential target genes, crosstalk affects expression of only some (such as Id2 or, to a lesser degree, CD44), but not other (such as cyclinD1, c-Myc or EGFR) genes. This suggests the existence of mechanisms for gene-specific convergence of signaling pathways.
Nuclear receptors interact and recruit various regulatory complexes to target gene promoters. The protein composition of these complexes determines the overall transcriptional effect exerted by the receptor (Yanagisawa et al., 2002; Kitagawa et al., 2003; Ohtake et al., 2003) . Interaction of retinoid receptors with b-catenin at the Id2 gene WRE presumably leads to recruitment of repressor complexes containing histone deacetylase and demethylase activities. Indeed, we were able to detect a retinoid-dependent recruitment to WRE in the Id2 gene promoter of LSD1 demethylase (Figure 5a ), shown to be essential for histone H3 Lys-4 demethylation (Shi et al., 2004; Lee et al., 2005) . As histone demethylases and deacetylases are believed to be present in non-related regulatory complexes, the observed pattern of histone modification at the Id2 gene implies sequential or independent recruitment to the WRE of different chromatin remodeling complexes. For prospective studies, the data presented here raise an important question about the factors and mechanisms that specify which potential target genes are affected by crosstalk of signaling pathways. Determination of the composition of retinoid-dependent regulatory complexes modulating Wnt target genes in keratinocytes may lead to understanding of such mechanisms and identification of novel therapeutic targets for skin cancer treatment.
Materials and methods
Cell lines A375 and SCC25 lines were purchased from the ATCC. A2058 and G361 lines were purchased from the Health Science Research Resources Bank (Osaka, Japan). The immortalized keratinocyte cell line HaCaT was generously provided by Dr N Fusenig (German Cancer Research Center, Heidelberg, Germany).
Proliferation assay
Cells were plated in 96-well plates in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% charcoalstripped fetal calf serum and treated with vehicle or 50 nM atRA (Sigma, St Louis, MO, USA). When indicated, cells were treated with 50 ng/ml Wnt3a (R&D Systems, Minneapolis, MN, USA) or 1 mM MG132 (Calbiochem, San Diego, CA, USA). Proliferation was assessed using Cell Proliferation ELISA, BrdU (Chemiluminescent) Kit (Roche Diagnostics, Mannheim, Germany) with TR717 Microplate Luminometer (Applied Biosystems, Foster City, CA, USA).
Transfection and reporter assay
Transfection and luciferase expression assays were performed as described previously (Kouzmenko et al., 2004) . Cells transfected with RARE-tk-Luc reporter were treated with vehicle or 50 nM atRA.
siRNA experiments Cells were transfected with siRNA duplexes targeting bcatenin mRNA (Ambion, siRNA ID#42816, Austin, TX, USA), or with a mixture of siRNA duplexes targeting CCTGTGGACGACCCGATGAGC and GATCGCCCTGG ACTCGCATCC sequences in the Id2 gene (Baghdoyan et al., 2005) . siRNA targeting AAGATGAACTTCAGGGTCAGC sequence in the GFP gene or non-targeting Silencer Negative Control#1 siRNA (Ambion) were used in control experiments. Cells were transfected twice with given siRNA at 48 h interval, plated 12 h after the last round of transfection into 96-well plates and treated with vehicle or 50 nM atRA for the next 48 h before the proliferation assay.
RT-PCR
Total RNA was prepared using Isogen (Nippon Gene, Toyama, Japan) and reverse transcription and PCR reagents were from Takara (Otsu, Japan). Real time PCR was performed with SYBR Premix Ex Taq (Takara) and monitored using Smart Cycler II apparatus and software (Cepheid, Sunnyvale, CA, USA).
ChIP assay
The ChIP assay was performed as described earlier (Kouzmenko et al., 2004) . ChIP grade or ChIP assay tested antibodies were purchased from Upstate (Lake Placid, NY, USA), Abcam (Cambridge, UK) or Santa Cruz Biotechnology (Santa Cruz, CA, USA). For RAR ChIP, we used anti-RAR M-454 antibody (Santa Cruz Biotechnology) that recognized all three RAR isoforms. At least two independent pairs of primers were used for PCR at the WRE of the each Id2, c-myc and cyclin D1 gene promoter.
